Medical and Psychiatric Effects of Long-Term Dependence on High Dose of tramadol

REFERENCES

• Abbas, R. A., Hammam, R. A. M., El-Gohary, S. S., Sabik, L. M. E., & Hunter, M. S. (2013). Screening for common mental disorders and substance abuse among temporary hired cleaners in Egyptian Governmental Hospitals, Zagazig City, Sharqia Governorate. International Journal of Occupational Environmental and Medicine, 4(1), 13–26.
   Google Scholar
• Abd-El-Fattah, S. (2007). Is the aggression questionnaire bias-free? A Rasch analysis. International Education Journal, 8(2), 237–248.
   Google Scholar
• Atici, S., Cinel, I., Cinel, L., Doruk, N., Eskandari, G., & Oral, U. (2005). Liver and kidney toxicity in chronic use of opioids: An experimental long-term treatment model. Journal of Bioscience, 30(2), 245–252.
   PubMed Web of Science ®Google Scholar
• Bamigbade, T., Davidson, C., Langford, R., & Stamford, J. (1997). Actions of tramadol, its enantiomers and principal metabolite, O-desmethyltramadol, on serotonin (5-HT) efflux and uptake in the rat dorsal raphe nucleus. British Journal of Anaesthesia, 79(3), 352–356.
   Google Scholar
• Barsotti, C., Mycyk, M., & Reyes, J. (2003). Withdrawal syndrome from tramadol hydrochloride. American Journal of Emergency Medicine, 21(1), 87–88.
   PubMed Web of Science ®Google Scholar
• Beck, A. T., Ward, C. H., Mendelson, M., Mock, J., & Erbaugh, J. (1961). An inventory for measuring depression. Archives of General Psychiatry, 4(6), 561–571.
   PubMed Web of Science ®Google Scholar
• Cheng, J. T., Liu, I. M., Chi, T. C., Tzeng, T. F., Lu, F. H., & Chang, C. J. (2001). Plasma glucose-lowering effect of tramadol in streptozotocin-induced diabetic rats. Diabetes, 50(12), 2815–2821.
   PubMed Web of Science ®Google Scholar
• Falls, A. B., & Gurrera, R. (2014). Serotonin syndrome in a patient on tramadol, bupropion, trazodone, and oxycodone. Psychosomatics, 55(3), 305–309.
   Google Scholar
• Fateem, L. (1994). Hamilton anxiety rating scale (Arabic translation). Cairo, Egypt: The Anglo Egyptian Bookshop.
   Google Scholar
• Frink, M. C., Hennies, H. H., Englberger, W., Haurand, M., & Wilffert, B. (1996). Influence of tramadol on neurotransmitter systems of the rat brain. Arzneimittel-Forschung, 46(11), 1029–1036.
   PubMed Web of Science ®Google Scholar
• Ghanem, M., Sheehan, D., Omar, A., Sneehan, K., ElRasheed, A., & EL-Marghany, H. M. (2002). Comparison of the MINI with the composite international diagnostic interview (CIDI): In an Egyptian sample presenting with psychotic disorder. Cairo, Egypt: Ain Shams Univeristy.
   Google Scholar
• Ghareeb, G. (2000). Psychometric characteristic of the Beck Depression Inventory BDI-II with Egyptian subjects. The Egyptian Psychologist, 10(4), 593–624.
   Google Scholar
• Gillen, C., Haurand, M., Kobelt, D., & Wnendt, S. (2000). Affinity potency and efficacy of tramadol and its metabolites at the cloned human μ-opioid receptor. Naunyn Schmiedebergs Archives of Pharmacology, 362(2), 116–121.
   PubMed Web of Science ®Google Scholar
• Gobbi, M., Moia, M., Pirona, L., Ceglia, I., Reyes-Parada, M., Scorza, C., & Mennini, T. (2002, September). “p-Methylthioamphetamine and 1-(m-chlorophenyl)piperazine, two non-neurotoxic 5-HT releasers in vivo, differ from neurotoxic amphetamine derivatives in their mode of action at 5-HT nerve endings in vitro. Journal of Neurochemistry, 82(6), 1435–1443.
   Google Scholar
• Goodman, W. K., Price, L. H., Rasmussen, S. A., Mazure, C., Fleischmann, R. L., Hill, C. L., …Charney, D. S. (1989). The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Archives of General Psychiatry, 46, 1006–1011.
   PubMed Web of Science ®Google Scholar
• Hamilton, M. (1959). The assessment of anxiety states by rating. British Journal of Medical Psychology, 32, 50–55.
   PubMed Web of Science ®Google Scholar
• Hara, K., Minami, K., & Sata, T. (2005). The effects of tramadol and its metabolite on glycine, gamma-aminobutyric acidA, and N-methyl-D-aspartate receptors expressed in Xenopus oocytes. Anesthesia and Analgesia, 100(5), 1400–1405.
   PubMed Web of Science ®Google Scholar
• Hennies, H., Friderichs, E., & Schneider, J., (1988). Receptor binding, analgesic and antitussive potency of tramadol and other selected opioids. Arzneimittel-Forschung, 38(7), 877–880.
   PubMed Web of Science ®Google Scholar
• Hopwood, S. E., Owesson, C. A., Callado, L. F., McLaughlin, D. P., & Stamford, J. A. (2001). Effects of chronic tramadol on pre- and post-synaptic measures of monoamine function. Journal of Psychopharmacology, 15(3), 147–153.
   PubMed Web of Science ®Google Scholar
• Kay, S., Fiszbein, A., & Opler, L., (1987). The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bulletin, 13(2), 261–276.
   PubMed Web of Science ®Google Scholar
• Micó, J., Ardid, D., Berrocoso, E., & Eschalier, A., (2006). Antidepressants and pain. Trends in Pharmacological Sciences, 27(7), 348–354.
   PubMed Web of Science ®Google Scholar
• Mohamed, M., (2010). Yale-Brown obsessive compulsive scale: Arabic translated version. Cairo, Egypt: Dar El-Anglo.
   Google Scholar
• Nazarzadeh, M., Bidel, Z., & Carson, K. (2014). The association between tramadol misuse and other substances use in adolescent population: Phase I of a prospective survey. Addictive Behaviors, 39(1), 333–337.
   PubMed Web of Science ®Google Scholar
• Ogata, J., Minami, K., Uezono, Y., Okamoto, T., Shiraishi, M., Shigematsu, A., & Ueta, Y. (2004). The inhibitory effects of tramadol on 5-hydroxytryptamine type 2C receptors expressed in Xenopus oocytes. Anesthesia and Analgesia, 98(5), 1401–1406.
   Google Scholar
• Okasha, A. (2004). Focus on psychiatry in Egypt. The British Journal of Psychiatry, 185, 266–272.
   PubMedGoogle Scholar
• Okasha, A., Khalil, A., & Fahmy, M. (1999). Psychological understanding of Egyptian heroin users. Egyptian Journal of Psychiatry, 13, 37–49.
   Google Scholar
• Radbruch, L., Grond, S., & Lehmann, K. (1996). A risk-benefit assessment of tramadol in the management of pain. Drug Safety, 15(1), 8–29.
   Google Scholar
• Raffa, R. (2006). Pharmacological aspects of successful long-term analgesia. Clinical Rheumatology, 25(Suppl 1), S9–S15.
   PubMed Web of Science ®Google Scholar
• Rajabizadeh, G., Kheradmand, A., & Nasirian, M. (2009). Psychosis following tramadol withdrawal. Addiction and Health, 1(1), 58–61.
   Google Scholar
• Reimann, W., & Schneider, F. (1998). Induction of 5-hydroxytryptamine release by tramadol, fenfluramine and reserpine. European Journal of Pharmacology, 349(2–3), 199–203.
   Google Scholar
• Ripamonti, C., Fagnoni, E., & De Conno, F. (2004). Withdrawal syndrome after delayed tramadol intake. The American Journal of Psychiatry, 161(12), 2326–2327.
   Google Scholar
• Rojas-Corrales, M., Berrocoso, E., Gibert-Rahola, J., & Micó, J. (2004). Antidepressant-like effect of tramadol and its enantiomers in reserpinized mice: Comparative study with desipramine, fluvoxamine, venlafaxine and opiates. Journal of Psycho-Pharmacology, 18(3), 404–411.
   PubMed Web of Science ®Google Scholar
• Rojas-Corrales, M., Gibert-Rahola, J., & Micó, J. (1998). Tramadol induces antidepressant-type effects in mice. Life Sciences, 63(12), PL175–PL180.
   PubMed Web of Science ®Google Scholar
• Senay, E. C., Adams, E. H., Geller, A., Inciardi, J. A., Muñoz, A., Schnoll, S. H., …Cicero, T. J. (2003). Physical dependence on Ultram (tramadol hydrochloride): Both opioid-like and atypical withdrawal symptoms occur. Drug and Alcohol Dependence, 69(3), 233–241.
   PubMed Web of Science ®Google Scholar
• SFDA. (2008). Narcotic drugs and psychotropic drugs directory, 7th ed. Beijing, China: SFDA.
   Google Scholar
• SFDA. (2009). Annual report of national drug abuse. National drug abuse monitoring center. Beijing, China: SFDA
   Google Scholar
• SFDA. (2010). Annual report of national drug abuse. National drug abuse monitoring center. Beijing, China: SFDA
   Google Scholar
• SFDA. (2011). Annual report of national drug abuse. National drug abuse monitoring center. Beijing, China: SFDA
   Google Scholar
• SFDA. (2012). Annual report of national drug abuse. National drug abuse monitoring center. Beijing, China: SFDA
   Google Scholar
• Sheehan, D. V., Lecrubier, Y., Harnett-Sheehan, K., Janavs, J., Weiller, E., Bonara, L. I., …Dunbar, G. C. (1997). Reliability and validity of the MINI (mini international neuropsychiatric interview) according to SCID-P. European Psychiatry, 12, 232–241.
   Web of Science ®Google Scholar
• Tao, Q., Stone, D. J., Borenstein, M. R., Codd, E. E., Coogan, T. P., Desai-Krieger, D., …Raffa, R. B. (2002). Differential tramadol and O-desmethyl metabolite levels in brain vs. plasma of mice and rats administered tramadol hydrochloride orally. Journal of Clinical Pharmacology Therapy, 27, 99–106.
   PubMed Web of Science ®Google Scholar
• WHO. (1992). WHO expert committee on drug dependence. (Twenty-eighth report). Geneva, Switzerland: WHO.
   Google Scholar
• WHO. (2000). WHO expert committee on drug dependence. (Thirty-second report). Geneva, Switzerland: WHO.
   Google Scholar
• WHO. (2006). WHO expert committee on drug dependence. (Thirty-fourth report). Geneva, Switzerland: WHO.
   Google Scholar
• Yang, H., Jin, X., KeLam, C., & Yan, S. (2011). Oxidative stress and diabetes mellitus. Clinical Chemistry and Laboratory Medicine, 49(11), 1773–1782.
   PubMed Web of Science ®Google Scholar
• Yates, W. R., Nguyen, M. H., & Warnock, J. K. (2001). Tramadol dependence with no history of substance abuse. American Journal of Psychiatry, 158(6), 964.
   PubMed Web of Science ®Google Scholar
• Zhuo, H., Huang, L., Huang, H., & Cai, Z. (2012). Effects of chronic tramadol exposure on the zebrafish brain: A proteomic study. Journal of Proteomics, 75(11), 3351–3364.
   Google Scholar